BICYCLE THERAPEUTICS PLC financial statements (2021 and earlier)

Company profile

Business Address B900 BABRAHAM RESEARCH CAMPUS
CAMBRIDGE, CB22 3AT
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13692
Cash and cash equivalents13692
Receivables50
Other undisclosed current assets1412
Total current assets:156104
Noncurrent Assets
Operating lease, right-of-use asset12
Property, plant and equipment22
Other noncurrent assets22
Total noncurrent assets:56
TOTAL ASSETS:161110
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities138
Accounts payable12
Accrued liabilities126
Deferred revenue101
Total current liabilities:239
Noncurrent Liabilities
Long-term debt and lease obligation151
Long-term debt, excluding current maturities15 
Operating lease, liability01
Liabilities, other than long-term debt287
Deferred revenue255
Other liabilities32
Total noncurrent liabilities:438
Total liabilities:6617
Stockholders' equity
Stockholders' equity attributable to parent9593
Common stock00
Additional paid in capital250195
Accumulated other comprehensive loss(3)(2)
Accumulated deficit(152)(101)
Total stockholders' equity:9593
TOTAL LIABILITIES AND EQUITY:161110

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
Gross profit:1014
Operating expenses(62)(40)
Operating loss:(52)(26)
Nonoperating income (expense)0(5)
Foreign currency transaction gain, before tax1 
Other nonoperating expense (5)
Interest and debt expense(0) 
Loss from continuing operations before equity method investments, income taxes:(52)(31)
Other undisclosed income from continuing operations before income taxes0 
Loss from continuing operations before income taxes:(52)(31)
Income tax benefit10
Net loss available to common stockholders, diluted:(51)(31)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
Net loss:(51)(31)
Comprehensive loss:(51)(31)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2)0
Comprehensive loss, net of tax, attributable to parent:(53)(30)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: